Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 50%
Negative

Negative
Zacks Investment Research
7 days ago
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.
Reasons to Retain STE Stock in Your Portfolio for Now
Positive
MarketBeat
14 days ago
STERIS Q4 Earnings Call Highlights
STERIS NYSE: STE reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.
STERIS Q4 Earnings Call Highlights
Negative
Zacks Investment Research
17 days ago
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
Neutral
Seeking Alpha
17 days ago
STERIS plc (STE) Q4 2026 Earnings Call Transcript
STERIS plc (STE) Q4 2026 Earnings Call Transcript
STERIS plc (STE) Q4 2026 Earnings Call Transcript
Negative
Zacks Investment Research
18 days ago
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Positive
Reuters
18 days ago
Steris forecasts 2027 profit above estimates, banks on procedure-driven demand
Medical equipment maker Steris forecast fiscal 2027 profit above Wall Street expectations ​on Monday, betting on strong demand ‌for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.
Steris forecasts 2027 profit above estimates, banks on procedure-driven demand
Neutral
GlobeNewsWire
18 days ago
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
Neutral
GlobeNewsWire
22 days ago
STERIS Appoints Pierre Boulud to Board of Directors
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.
STERIS Appoints Pierre Boulud to Board of Directors
Neutral
GlobeNewsWire
24 days ago
STERIS Announces Dividend of $0.63 per share
DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.
STERIS Announces Dividend of $0.63 per share
Neutral
Zacks Investment Research
25 days ago
STERIS' Q4 Earnings on Deck: What's in Store for the Stock?
STERIS plc STE is scheduled to release fourth-quarter fiscal 2026 results on May 12, after market close.
STERIS' Q4 Earnings on Deck: What's in Store for the Stock?